Enhancing recognition of early Parkinsonism in the community

Movement Disorders

Volumn 19, Issue 5, 2004, Pages 505-512

  Höglinger, Günter U ^a   Rissling, Ida ^a   Metz, Aline ^a   Ries, Vincent ^a   Heinermann, Anne ^a   Prinz, Helge ^a   Spieker, Sybille ^a   Deuschl, Günter ^b   Baum, Erika ^a   Oertel, Wolfgang H ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

123I FP CIT SPECT; General practitioner; Parkinson's disease; Parkinsonism; Questionnaire; Screening

Indexed keywords

6 FLUORODOPA; TROPANE DERIVATIVE; 2 CARBOMETHOXY 8 (3 FLUOROPROPYL) 3 (4 IODOPHENYL)TROPANE; 2-CARBOMETHOXY-8-(3-FLUOROPROPYL)-3-(4-IODOPHENYL)TROPANE; DIAGNOSTIC AGENT; RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; COMMUNITY CARE; CONSULTATION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; MALE; MEDICAL SPECIALIST; NEUROLOGIC EXAMINATION; NEUROLOGY; PARKINSONISM; PRIORITY JOURNAL; PUBLICATION; QUESTIONNAIRE; SCREENING TEST; SENSITIVITY ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STANDARDIZATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS; BRAIN; DIFFERENTIAL DIAGNOSIS; MASS SCREENING; METABOLISM; METHODOLOGY; MIDDLE AGED; PRIMARY HEALTH CARE; RECOGNITION; REPRODUCIBILITY; VALIDATION STUDY;

AGED; AGED, 80 AND OVER; BRAIN; COMMUNITY HEALTH SERVICES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MASS SCREENING; MIDDLE AGED; PARKINSONIAN DISORDERS; PRIMARY HEALTH CARE; QUESTIONNAIRES; RECOGNITION (PSYCHOLOGY); REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 4544317800     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20033     Document Type: Article

References (20)

1. Koller WC, Montgomery EB. Issues in the early diagnosis of Parkinson's disease. Neurology 1997;49(Suppl.):10-25.
2. Schoenberg BS, Anderson DW, Haerer AF. Prevalence of Parkinson's disease in the biracial population of Copiah County, Mississippi. Neurology 1985;35:841-845.
3. Morgante L, Rocca WA, Di Rosa AE, et al. Prevalence of Parkinson's disease and other types of Parkinsonism: a door-to-door survey in three Sicilian municipalities. Neurology 1992;42:1901-1907.
4. De Pedro Cuesta J. Parkinson's disease occurrence in Europe. Acta Neurol Scand 1991;84:357-365.
5. Kis B, Schrag A, Ben-Shlomo Y, et al. Novel three-stage ascertainment method. Prevalence of PD and Parkinsonism in South Neurol, Italy. Neurology 2002;58:1820-1825.
6. Gonera EG, van't Hof M, Berger HJ, van Weel C, Horstink MW. Symptoms and duration of the prodromal phase in Parkinson's disease. Mov Disord 1997;12:871-876.
7. Riederer P, Gille G, Muller T, et al. Practical importance of neuroprotection in Parkinson's disease. J Neurol 2002; 249(Suppl.):53-56.
8. Li SC, Schoenberg BS, Wang CC, et al. A prevalence survey of Parkinson's disease and other movement disorders in the People's Republic of China. Arch Neurol 1985;42:655-657.
9. Bharucha NE, Bharucha EP, Bharucha AE, Bhise AV, Schoenberg BS. Prevalence of Parkinson's disease in Parsi Community of Bombay, India. Arch Neurol 1988;45:1321-1323.
10. Anderson DW, Schoenberg BS, Haerer AF. Prevalence surveys of neurological disorders: methodological implications of the Copiah County Study. J Clin Epidemiol 1988;41:339-345.
11. Meneghini F, Rocca WA, Grigoletto F, et al. Door-to-door prevalence survey of neurological diseases in a Sicilian population. Background and methods. The Sicilian Neuro-Epidemiologic Study (SNES) Group. Neuroepidemiology 1991;10:70-85.
12. Tison F, Dartigues JF, Dubes L, Zuber M, Alperovitch A, Henry P. Prevalence of Parkinson's disease in the elderly: a population study in Gironde, France. Acta Neurol Scand 1994;90:111-115.
13. Duarte J, Claveria LE, De Pedro-Cuesta J, et al. Screening Parkinson's disease: a validated questionnaire of high specificity and sensitivity. Mov Disord 1995;10:643-649.
14. Pramstaller PP, Falk M, Schoenhuber R, Poewe W. Validation of a mail questionnaire for Parkinsonism in two languages (German and Italian). J Neurol 1999;246:79-86.
15. Chan DK, Hung WT, Wong A, Hu E, Beran RG. Validating a screening questionnaire for Parkinsonism in Australia. J Neurol Neurosurg Psychiatry 2000;69:117-120.
16. Tanner CM, Gilley DW, Goetz CG. A brief screening questionnaire for Parkinsonism (abstract). Ann Neurol 1990;18:267-268.
17. Sevillano MD, de Pedro-Cuesta J, Duarte J, Claveria LE. Field validation of a method for population screening of parkinsonism. Mov Disord 2002;17:258-264.
18. Gibb WR, Lees A. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752.
19. Benamer TS, Patterson J, Grosset DG, et al. Accurate differentiation of Parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord 2000;15:503-510.
20. de Rijk MC, Launer LJ, Berger K, et al. Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000;54(Suppl.):21-23.